Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2026-02-01 @ 2:38 PM
Study NCT ID:
NCT00632359
Status:
COMPLETED
Last Update Posted:
2020-02-10
First Post:
2008-03-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2007-0213
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |